Found on
Group by:
Title Date Type
Pharmacy-Based Immunization Delivery 2021
  Coming Soon in 2021! Supported by an educational grant from Merck, APhA will be conducting special virtual offerings of the Pharmacy-Based Immunization Delivery certificate training program for only $199. These will be announced in the spring so keep checking back to this page as we get…
Jul 07, 2017 Basic page
Education During COVID-19
  APhA's Education During COVID-19 is a library of approved CPE for pharmacists and pharmacy technicians. APhA Education During COVID-19: Pfizer-BioNTech COVID-19 Vaccine Overview (December 10) New, free 1-hour CPE is a comprehensive overview of the information that pharmacists…
Jul 29, 2020 Basic page
APhA COVID-19 Resources: Know the Facts
Practical Information for Pharmacists to Know Now COVID-19 Vaccines COVID-19 Vaccine Summary Chart: A reference that compares key information about the Pfizer-BioNTech, Moderna, and Janssen COVID-19 vaccines and summarizes the CDC's clinical considerations. (PDF) - NEW!…
Apr 02, 2020 Basic page
Biden promises enough coronavirus vaccine for 'every adult in America' by the end of May
Washington Post (03/02/21) Wan, William; Shammas, Brittany; Parker, Ashley; et al.
President Biden announced Tuesday there will be ample COVID-19 vaccine for "every adult in America" to be protected by the end of May. That milestone previously was set for late July, but the pace has accelerated due to Johnson & Johnson's single-dose vaccine receiving emergency use…
Mar 02, 2021 Publication Pharmacy Today Daily Edition
America's most prized leftovers: COVID vaccines
New York Times (03/03/21) Healy, Jack
Leftover coronavirus vaccine—unused due to missed appointments, miscalculations, or unforeseen circumstances—has become a hot commodity in a market where demand continues to outstrip supply. Because the Moderna and Pfizer doses expire hours after being thawed and mixed, pharmacies,…
Mar 02, 2021 Publication Pharmacy Today Daily Edition
Severe hypoglycemia risk with long-acting insulin analogs vs. neutral protamine Hagedorn insulin
JAMA Internal Medicine (03/01/21) Bradley, Marie C.; Chillarige, Yoganand; Lee, Hana; et al.
Compared with neutral protamine Hagedorn (NPH) insulin, researchers say long-acting insulin analogs may lower the risk of severe hypoglycemia in older adults with type 2 diabetes. The implication comes from a large-scale retrospective analysis of Medicare beneficiaries aged 65 years and older. The…
Mar 02, 2021 Publication Pharmacy Today Daily Edition
A COVID vaccine side effect, enlarged lymph nodes, can be mistaken for cancer
New York Times (03/01/21) Grady, Denise
Swollen lymph nodes in the armpit or near the collarbone can occur after a person receives a COVID-19 vaccine, and may be mistaken as a sign of cancer. However, the swelling is a normal reaction by the immune system, and happens on the same side as the site of vaccination. It can also occur after…
Mar 02, 2021 Publication Pharmacy Today Daily Edition
WHO: New virus cases rising globally for first time in weeks
The Hill (03/02/21) Budryk, Zack
In a Monday briefing, the World Health Organization (WHO) said new cases of COVID-19 are rising globally for the first time in nearly 2 months. Michael Ryan, who oversees WHO's health emergencies program, noted that cases had risen over the last week in every region except Africa and the Western…
Mar 02, 2021 Publication Pharmacy Today Daily Edition
State officials, community leaders try to dissuade residents from vaccine 'shopping'
Boston Globe (03/01/21) Weisman, Robert
State and community leaders in Massachusetts are discouraging residents from "shopping" for a particular brand of COVID-19 vaccine, asserting that all three types now available are highly protective against serious disease from the coronavirus. Officials are worried that some consumers, in…
Mar 02, 2021 Publication Pharmacy Today Daily Edition
WHO panel: Hydroxychloroquine should not be used to prevent COVID-19
The Hill (03/01/21) Weixel, Nathaniel
A new recommendation from the World Health Organization (WHO) states that hydroxychloroquine should not be used to prevent COVID-19, based on several clinical trials of more than 6,000 people. The studies indicate that the anti-inflammatory drug had no meaningful effect on death or hospital…
Mar 02, 2021 Publication Pharmacy Today Daily Edition